Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) would like to provide an update on the Company’s dispensary in Desert Hot Springs, California. The dispensary continues to increase sales since acquisition with weekly and monthly promotions. Furthermore, the implementation of a live inventory system has ensured accurate information is relayed in “real-time” to our existing patrons and the 3.5 million visitors to the popular Coachella Valley area.
The Company has been using unique promotions that have been extremely successful during the past six weeks of ownership. For example, the dispensary has partnered with adjacent retailers to perform cross promotions which have been well received by the community patrons and appreciated by the partner retailers. Two of our partner retailer promotions resulted in a 118% daily sales increase when compared to our daily average sales. However, the true strength of the dispensary is our staff. They continue to be an integral component of our success, building our reputation of providing superior service and product knowledge to our clientele and being a reputable business community member in the Desert Hot Springs area.
In addition, Weedmaps, in conjunction with the integrated MJ Platform inventory management system, has increased traffic by providing us the ability to give our patients and adult consumers (over the age of 21) easy access to the most reliable “real-time” information about our location, hours, specials, promotional days, strains, products, and reviews. Visit our website, greenleafwellnessdhs.com and click “Visit Us On Weedmaps” for more information.
“We will continue to develop exclusive promotions and special products which have proven to be well received by the “adult use” community of Desert Hot Springsand surrounding valley.” Linda Sampson, CEO.
ABOUT MARAPHARM VENTURES INC.
Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide.
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQX, and in Europe, ticker symbol 2M0 on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.
Neither the CSE, the FSE nor the OTCQX® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQX® accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicable state in which they operate.
Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change. Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Marapharm’s ability to access private and public capital could be affected and or could not be available to support continuing operations. Marapharm’s business is conducted in a manner consistent with state law and is in compliance with licensing requirements.
Copies of licenses are posted on Marapharm’s website. Marapharm has internal compliance procedures in place and has compliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and state law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance in Canada and the US.
FORWARD – LOOKING STATEMENTS:
Certain statements contained in this news release constitute forward looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, ‘may”, “will”, “project”, “should”, ‘believe”, and similar expressions are intended to identify forward- looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward- looking statements and are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.
SOURCE Marapharm Ventures Inc.
View original content: http://www.newswire.ca/en/releases/archive/April2018/06/c1289.html
www.marapharm.com or Linda Sampson, CEO, 778-583-4476, email firstname.lastname@example.orgCopyright CNW Group 2018